This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/515291-indian-state-rejects-covaxin-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Indian state asks govt to stop sending Covaxin vaccine doses as it won't use them until efficacy data published | Indian state asks govt to stop sending Covaxin vaccine doses as it won't use them until efficacy data published |
| (7 months later) | |
| Local authorities in the Indian state of Chhattisgarh have asked the government to stop sending doses of the country's homegrown Covid-19 vaccine until proper efficacy data for the jab has been provided. | Local authorities in the Indian state of Chhattisgarh have asked the government to stop sending doses of the country's homegrown Covid-19 vaccine until proper efficacy data for the jab has been provided. |
| The health minister of the central-eastern state, T.S. Singh Deo, has written to his national counterpart, Harsh Vardhan, asking for all deliveries of the Covaxin vaccine to be stopped to “avoid the wastage” of the drug. | The health minister of the central-eastern state, T.S. Singh Deo, has written to his national counterpart, Harsh Vardhan, asking for all deliveries of the Covaxin vaccine to be stopped to “avoid the wastage” of the drug. |
| “There's an inhibition/concern among the community in general regarding the use of Covaxin,” Singh Deo said in the letter, which he posted to Twitter on Thursday. | “There's an inhibition/concern among the community in general regarding the use of Covaxin,” Singh Deo said in the letter, which he posted to Twitter on Thursday. |
| “This concern arises from the fact that the clinical trials of Phase 3 are yet to be completed.” | “This concern arises from the fact that the clinical trials of Phase 3 are yet to be completed.” |
| Singh Deo said vials of the vaccine currently don't display an expiry date, and asked that the Indian government “reconsider” its decision to ship doses to Chhattisgarh until Phase III trial data is made available. | Singh Deo said vials of the vaccine currently don't display an expiry date, and asked that the Indian government “reconsider” its decision to ship doses to Chhattisgarh until Phase III trial data is made available. |
| Opposition-ruled Chhattisgarh has received 588,000 doses of the AstraZeneca vaccine but is also set to get some of the 10 million doses of the Covaxin jab developed by Bharat Biotech and the Indian Council of Medical Research. | Opposition-ruled Chhattisgarh has received 588,000 doses of the AstraZeneca vaccine but is also set to get some of the 10 million doses of the Covaxin jab developed by Bharat Biotech and the Indian Council of Medical Research. |
| The state-funded medical body has said efficacy data from a Phase III trial of the vaccine, involving 26,000 participants, would be released in March. | The state-funded medical body has said efficacy data from a Phase III trial of the vaccine, involving 26,000 participants, would be released in March. |
| However, India's drug regulator approved Covaxin in early January without releasing the efficacy data, sparking outrage among Indian medical experts. | However, India's drug regulator approved Covaxin in early January without releasing the efficacy data, sparking outrage among Indian medical experts. |
| The health watchdog All India Drug Action Network said it was “shocked” and had “intense concerns” over the move, while Indian MP Shashi Tharoor said the regulator's decision was “premature and could be dangerous.” | The health watchdog All India Drug Action Network said it was “shocked” and had “intense concerns” over the move, while Indian MP Shashi Tharoor said the regulator's decision was “premature and could be dangerous.” |
| Since January 16, India has vaccinated 7 million key workers with Bharat Biotech and AstraZeneca jabs. | Since January 16, India has vaccinated 7 million key workers with Bharat Biotech and AstraZeneca jabs. |
| The country has reported more than 10 million Covid-19 cases, the highest in the world after the US, and has registered 155,000 deaths from the virus during the pandemic. | The country has reported more than 10 million Covid-19 cases, the highest in the world after the US, and has registered 155,000 deaths from the virus during the pandemic. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |